Characteristics and Changes of Pediatric Therapeutic Trials under the Best Pharmaceuticals for Children Act.

Avant, Debbie; Wharton, Gerold T; Murphy, Dianne

Avant, Debbie; Wharton, Gerold T; Murphy, Dianne.

Afiliação

Avant D; Offices of Pediatric Therapeutics, Office of the Commissioner, US Food and Drug Administration, Silver Spring, MD. Electronic address: Debbie.Avant@fda.hhs.gov.
Wharton GT; Offices of Pediatric Therapeutics, Office of the Commissioner, US Food and Drug Administration, Silver Spring, MD.
Murphy D; Offices of Pediatric Therapeutics, Office of the Commissioner, US Food and Drug Administration, Silver Spring, MD.

J Pediatr ; 192: 8-12, 2018 01.

Article em En | MEDLINE | ID: mdl-29029810

Assuntos

Desenvolvimento de Medicamentos; United States Food and Drug Administration; Criança; Rotulagem de Medicamentos; Humanos

Palavras-chave

FDA; Pediatric clinical trials; pediatric drug development; pediatric labeling

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: United States Food and Drug Administration / Desenvolvimento de Medicamentos Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google